Monday, April 3, 2017

#Cannabis Testing Market to Reach $1.4 Billion by 2021 - Driven by Growing Number of Cannabis Testing Laboratories

#Cannabis Testing Market to Reach $1.4 Billion by 2021 - Driven by Growing Number of Cannabis Testing Laboratories

DUBLIN - March 31, 2017 ( Newswire) Research and Markets has announced the addition of the "Cannabis Testing Market - Global Forecast to 2021" report to their offering.
The global cannabis testing market is expected to reach USD 1,416.3 Million by 2021 from USD 822.0 Million in 2016, at a CAGR of 11.5% during the forecast period (2016-2021).
The growth in this market is mainly driven by factors such as legalization of medical cannabis, coupled with the growing number of cannabis testing laboratories (specifically in the U.S.); growing adoption of LIMS in cannabis testing laboratories; and increasing awareness through conferences, symposia, and workshops. On the other hand, the high cost of analytical instruments, presence of alternative technologies, and dearth of skilled professionals are some of the major factors that are expected to restrain the growth of this market in the coming years.
This report segments the cannabis testing market into cannabis testing products (analytical instruments and consumables) & software (Cannabis LIMS), cannabis testing services, end users, and regions. On the basis of products, the market is broadly categorized into two segments, namely, analytical instruments and consumables. The consumables segment is expected to grow at the highest CAGR during the forecast period owing to their recurring requirement and repetitive usage.
Companies Mentioned:
  • AB Sciex LLC
  • Accelerated Technology Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Digipath, Inc.
  • Millipore Sigma
  • Perkinelmer, Inc.
  • Pharmlabs LLC
  • Restek Corporation
  • SC (Science of Cannabis) Laboratories, Inc.
  • Shimadzu Corporation
  • Steep Hill Halent Laboratories, Inc.
  • Waters Corporation
Key Topics Covered:
  • Introduction
  • Research Methodology
  • Executive Summary
  • Premium Insights
  • Market Overview
  • Industry Insights
  • Cannabis Testing Market, By Product and Software
  • Cannabis Testing Services Market, By Type
  • Cannabis Testing Market,By End User
  • Cannabis Testing Market, By Region
  • Competitive Landscape
  • Company Profiles
  • Appendix
For more information about this report visit
Media Contact:
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Like Marijuana Stocks? View our Marijuana / Hemp Stocks Directory
Global Cannabis Investing - features Investor Ideas Cannabis news

Watch the 420 Cannabis Investor video

More Info:

This news is published on the Newswire - a global digital news source for investors and business leaders
Disclaimer/Disclosure: is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info:
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: Global investors must adhere to regulations of each country.

No comments:

Post a Comment